相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
Rana Abdelnabi et al.
ANTIVIRAL RESEARCH (2022)
A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection
Patricia Perez et al.
FRONTIERS IN IMMUNOLOGY (2022)
Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice
Adrian Lazaro-Frias et al.
NPJ VACCINES (2022)
COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice
Juan Garcia-Arriaza et al.
JOURNAL OF VIROLOGY (2021)
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
Lorena Sanchez-Felipe et al.
NATURE (2021)
Vaccine-induced immune thrombosis and thrombocytopenia syndrome following adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms and implications for future vaccine development
Paul Monagle et al.
IMMUNOLOGY AND CELL BIOLOGY (2021)
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
Nanda Kishore Routhu et al.
IMMUNITY (2021)
One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection
Ruikang Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS-CoV-2 vaccine candidates in the Syrian hamster model
Sreelekshmy Mohandas et al.
ISCIENCE (2021)
Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents
Berislav Bosnjak et al.
FRONTIERS IN IMMUNOLOGY (2021)
ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome
Alexander T. Baker et al.
SCIENCE ADVANCES (2021)
MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge
Clement A. Meseda et al.
NPJ VACCINES (2021)
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
Robert H Shaw et al.
LANCET (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications
Salim S. Abdool Karim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
COVID-19 and the intensive care unit: vaccines to the rescue
Kai Dallmeier et al.
INTENSIVE CARE MEDICINE (2021)
Variants of SARS-CoV-2
Adam S. Lauring et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters
Mijia Lu et al.
JOURNAL OF VIROLOGY (2021)
Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters
Rakesh Kulkarni et al.
PLOS ONE (2021)
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
Alina Tscherne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern
Lisa H. Tostanoski et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
Rana Abdelnabi et al.
EBIOMEDICINE (2021)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility
Jasper Fuk-Woo Chan et al.
CLINICAL INFECTIOUS DISEASES (2020)
Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples
Alessandro Manenti et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies
Niraj Mishra et al.
MBIO (2020)
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
Masaki Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
Jose Maria Diez et al.
IMMUNOTHERAPY (2020)
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
Robbert Boudewijns et al.
NATURE COMMUNICATIONS (2020)
DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus
Melanie Thompson et al.
PLOS ONE (2016)
Clinical applications of attenuated MVA poxvirus strain
Carmen Elena Gomez et al.
EXPERT REVIEW OF VACCINES (2013)
Clinical development of Modified Vaccinia virus Ankara vaccines
Sarah C. Gilbert
VACCINE (2013)
Viral Cross-Class Serpin Inhibits Vascular Inflammation and T Lymphocyte Fratricide; A Study in Rodent Models In Vivo and Human Cell Lines In Vitro
Kasinath Viswanathan et al.
PLOS ONE (2012)
Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic
Max Corbett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Virus distribution of the attenuated MVA and NYVAC poxvirus strains in mice
Carmen Elena Gomez et al.
JOURNAL OF GENERAL VIROLOGY (2007)